167 related articles for article (PubMed ID: 20880176)
41. Colorectal cancer screening with fecal occult blood testing (FOBT): an international perspective.
Achkar E; Moayyedi P
Am J Gastroenterol; 2006 Feb; 101(2):212. PubMed ID: 16454818
[No Abstract] [Full Text] [Related]
42. Colorectal cancer screening in rural and poor-resourced communities.
Preston MA; Glover-Collins K; Ross L; Porter A; Bursac Z; Woods D; Burton J; Crowell K; Laryea J; Henry-Tillman RS
Am J Surg; 2018 Aug; 216(2):245-250. PubMed ID: 28842164
[TBL] [Abstract][Full Text] [Related]
43. Impact of an educational video-based strategy on the behavior process associated with colorectal cancer screening: a randomized controlled study.
Gimeno-García AZ; Quintero E; Nicolás-Pérez D; Parra-Blanco A; Jiménez-Sosa A
Cancer Epidemiol; 2009 Oct; 33(3-4):216-22. PubMed ID: 19747893
[TBL] [Abstract][Full Text] [Related]
44. [Programme of screening for colorrectal cancer in the Valencia community, Spain: results of the first round (2005-2008)].
Málaga López A; Salas Trejo D; Sala Felis T; Ponce Romero M; Goicoechea Sáez M; Andrés Martínez M; Llorens Ivorra C; González Serrano I;
Rev Esp Salud Publica; 2010; 84(6):731-43. PubMed ID: 21327309
[TBL] [Abstract][Full Text] [Related]
45. Involvement of previous non-participants cannot fully compensate for lower participation in a second round of FIT-screening.
Denters MJ; Deutekom M; Bossuyt PM; van Rijn AF; Fockens P; Dekker E
Cancer Epidemiol; 2013 Jun; 37(3):330-5. PubMed ID: 23403127
[TBL] [Abstract][Full Text] [Related]
46. Equity of colorectal cancer screening: cross-sectional analysis of National Bowel Cancer Screening Program data for South Australia.
Ward PR; Javanparast S; Matt MA; Martini A; Tsourtos G; Cole S; Gill T; Aylward P; Baratiny G; Jiwa M; Misan G; Wilson C; Young G
Aust N Z J Public Health; 2011 Feb; 35(1):61-5. PubMed ID: 21299702
[TBL] [Abstract][Full Text] [Related]
47. Fecal occult blood test screening in the United kingdom.
Steele RJ
Am J Gastroenterol; 2006 Feb; 101(2):216-8. PubMed ID: 16454820
[No Abstract] [Full Text] [Related]
48. Experience of colorectal cancer screening using a home-administered kit for fecal occult blood tests among a Chinese worksite population in Taiwan.
Hou SI
Psychol Rep; 2005 Feb; 96(1):178-80. PubMed ID: 15825922
[TBL] [Abstract][Full Text] [Related]
49. Sociogeographical factors associated with participation in colorectal cancer screening.
Le Retraite L; Eisinger F; Loundou A; Rinaldi Y; Seitz JF; Auquier P
Gastroenterol Clin Biol; 2010 Oct; 34(10):534-40. PubMed ID: 20832216
[TBL] [Abstract][Full Text] [Related]
50. A Systematic Review of Repeat Fecal Occult Blood Tests for Colorectal Cancer Screening.
Murphy CC; Sen A; Watson B; Gupta S; Mayo H; Singal AG
Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):278-287. PubMed ID: 31740521
[TBL] [Abstract][Full Text] [Related]
51. What is the role of iFOBT in screening for colorectal cancer?
Ransohoff DF
Gut; 2007 Oct; 56(10):1343-4. PubMed ID: 17872566
[TBL] [Abstract][Full Text] [Related]
52. Novel Toilet Paper-Based Point-Of-Care Test for the Rapid Detection of Fecal Occult Blood: Instrument Validation Study.
Wang HY; Lin TW; Chiu SY; Lin WY; Huang SB; Hsieh JC; Chen HC; Lu JJ; Wu MH
J Med Internet Res; 2020 Aug; 22(8):e20261. PubMed ID: 32763879
[TBL] [Abstract][Full Text] [Related]
53. Fecal occult blood testing for colorectal cancer. Can we afford to do this?
Ahlquist DA
Gastroenterol Clin North Am; 1997 Mar; 26(1):41-55. PubMed ID: 9119439
[TBL] [Abstract][Full Text] [Related]
54. On the sensitivity of fecal occult blood test screening for colorectal cancer.
Lang CA; Ransohoff DF
J Natl Cancer Inst; 1997 Oct; 89(19):1392-3. PubMed ID: 9326904
[No Abstract] [Full Text] [Related]
55. Factors influencing participation in colorectal cancer screening programs in Spain.
Vanaclocha-Espi M; Ibáñez J; Molina-Barceló A; Pérez E; Nolasco A; Font R; Pérez-Riquelme F; de la Vega M; Arana-Arri E; Oceja M; Espinàs JA; Portillo I; Salas D;
Prev Med; 2017 Dec; 105():190-196. PubMed ID: 28887191
[TBL] [Abstract][Full Text] [Related]
56. Screening for colorectal cancer.
Austoker J; Hewitson P
BMJ; 2008 Nov; 337():a2207. PubMed ID: 19022839
[No Abstract] [Full Text] [Related]
57. Faecal occult blood test: current practice in a rural Queensland community.
Janda M; Hughes K; Tong S; Stanton WR; Aitken J; Clavarino A; Short L; Del Mar C; Leggett B; Newman B
Aust J Rural Health; 2002 Feb; 10(1):57-64. PubMed ID: 11952524
[TBL] [Abstract][Full Text] [Related]
58. Application of the fecal microRNA test to the residuum from the fecal occult blood test.
Yamazaki N; Koga Y; Yamamoto S; Kakugawa Y; Otake Y; Hayashi R; Saito N; Matsumura Y
Jpn J Clin Oncol; 2013 Jul; 43(7):726-33. PubMed ID: 23677957
[TBL] [Abstract][Full Text] [Related]
59. Cancer screening in Queensland men.
Carrière P; Baade P; Newman B; Aitken J; Janda M
Med J Aust; 2007 Apr; 186(8):404-7. PubMed ID: 17437394
[TBL] [Abstract][Full Text] [Related]
60. Population based screening in Scotland reduces bowel cancer deaths.
Wise J
BMJ; 2011 Nov; 343():d7304. PubMed ID: 22074773
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
